CLBT Cellebrite DI

• None no insider bought on the open market
• $3.1M sold by 4 insiders outside a trading plan
• $124K sold by 1 insider under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. David Barter CFO
   Sale
   $136K 12,134 shares at $11.21 3.6% of stake
   Traded Oct 16 Filed Oct 19
   ↗
3. Thomas E. Hogan Insider
   Sale
   $286K 25,299 shares at $11.29 3.2% of stake
   Traded Aug 25 Filed Aug 27
   ↗
4. David Nicholas Gee Chief Marketing Officer
   Planned sale
   $49K 4,323 shares at $11.36 3.1% of stake
   Traded Aug 24 Filed Aug 25
   ↗
5. Marcus Jewell Global Chief Revenue Officer
   Sale
   $141K 12,562 shares at $11.24 2.9% of stake
   Traded Aug 21 Filed Aug 24
   ↗
6. David Nicholas Gee Chief Marketing Officer
   Sale
   $25K 2,198 shares at $11.24 1.6% of stake
   Traded Aug 21 Filed Aug 24
   ↗
7. Marcus Jewell Global Chief Revenue Officer
   Sale
   $6,604 411 shares at $16.07 0.1% of stake
   Traded Aug 12 Filed Aug 13
   ↗
8. David Nicholas Gee Chief Marketing Officer
   Sale
   $3,696 230 shares at $16.07 0.2% of stake
   Traded Aug 12 Filed Aug 13
   ↗
9. David Barter CFO
   Sale
   $683K 41,734 shares at $16.38 11% of stake
   Traded Jul 8 Filed Jul 9
   ↗
10. Thomas E. Hogan CEO
    Sale
    $1.6M 103,188 shares at $15.76 15% of stake
    Traded Jul 2 Filed Jul 7
    ↗
11. David Nicholas Gee Chief Marketing Officer
    Planned sale
    $74K 5,673 shares at $13.13 3.8% of stake
    Traded May 21 Filed May 26
    ↗
12. Marcus Jewell Global Chief Revenue Officer
    Sale
    $162K 12,658 shares at $12.77 2.8% of stake
    Traded May 18 Filed May 19
    ↗
13. David Nicholas Gee Chief Marketing Officer
    Sale
    $2,966 228 shares at $13.01 0.2% of stake
    Traded May 12 Filed May 14
    ↗
14. Marcus Jewell Global Chief Revenue Officer
    Sale
    $4,983 383 shares at $13.01 0.1% of stake
    Traded May 12 Filed May 14
    ↗

Also filed in the last 12 months, not counted as buying or selling: 10 stock grants and 1 sale to cover taxes.